The stock's rise snapped a three-day losing streak.

This was the stock's third consecutive day of losses.

Quest Diagnostics DGX has achieved impressive growth over the past year, with its shares rising 38%. It has outperformed the industry’s 7.7% rise and the S&P 500 composite’s 17.1% gain. Presently ...

A Wall Street analyst issued contrasting ratings on Tuesday for two major diagnostic testing companies, upgrading shares of ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Three different kinds of medication, two cellphones and a planner were among the items taken from actor Gene Hackman’s New ...

Citigroup cut shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a neutral rating in a report ...

Citi downgraded Quest Diagnostics (DGX) to Neutral from Buy with an unchanged price target of $185. The firm believes Quest is well positioned ...

Quest Diagnostics Inc. DGX benefits from its robust utilization of the Advanced Diagnostics portfolio offerings. The company also expands through strategic acquisitions, completing eight ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Quest Diagnostics (DGX – Research Report) yesterday and set a price ...

Quest Diagnostics DGX has achieved impressive growth over the past year, with its shares rising 38%. It has outperformed the industry’s 7.7% rise and the S&P 500 composite’s 17.1% gain.